pentobarbital has been researched along with Dizzyness in 1 studies
Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objectives of this study were to describe the type and frequency of postdischarge adverse events related to sedation for elective diagnostic imaging in children and to determine if any patient or drug characteristics were associated with such adverse events." | 1.38 | Postdischarge adverse events related to sedation for diagnostic imaging in children. ( Chen, X; Kaila, R; Kannikeswaran, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaila, R | 1 |
| Chen, X | 1 |
| Kannikeswaran, N | 1 |
1 other study available for pentobarbital and Dizzyness
| Article | Year |
|---|---|
Postdischarge adverse events related to sedation for diagnostic imaging in children.
Topics: Child; Child, Preschool; Dizziness; Female; Fentanyl; Follow-Up Studies; Humans; Hypnotics and Sedat | 2012 |